Sign in Sign Up Free

Viking Global Investors LP

Activist investor & 5%+ owner · SC 13D/13G filings

Total Filings

93

Stocks Covered

35

Latest Filing

Nov 14, 2024

Filings

Tourmaline Bio, Inc.

SC 13G/A · Nov 14, 2024

0.0%

0 shares

Ginkgo Bioworks Holdings, Inc.

SC 13G/A · Nov 14, 2024

8.3%

3.6M shares

Edgewise Therapeutics, Inc.

SC 13G/A · Nov 14, 2024

1.6%

1.5M shares

PepGen Inc.

SC 13G/A · Nov 14, 2024

4.5%

1.5M shares

4D Molecular Therapeutics, Inc.

SC 13G/A · Nov 14, 2024

0.0%

0 shares

Roivant Sciences Ltd.

SC 13G/A · Nov 14, 2024

7.3%

54.1M shares

VIKING THERAPEUTICS, INC.

SC 13G/A · Nov 14, 2024

0.6%

722K shares

Verastem, Inc.

SC 13G/A · Nov 14, 2024

0.0%

0 shares

BridgeBio Pharma, Inc.

SC 13D/A · Nov 6, 2024

13.4%

25.1M shares

BioMarin Pharmaceutical Inc.

SC 13G · Sep 30, 2024

5.1%

9.8M shares

BridgeBio Pharma, Inc.

SC 13D/A · Aug 21, 2024

13.4%

25.1M shares

* Longboard Pharmaceuticals, Inc.

SC 13G · Jul 15, 2024

5.2%

1.8M shares

APi Group Corporation

SC 13G/A · Jun 18, 2024

9.9%

27.0M shares

* Inhibrx Biosciences, Inc.

SC 13G · Jun 7, 2024

12.3%

1.8M shares

Inhibrx, Inc.

SC 13G/A · Jun 3, 2024

0.0%

0 shares

Standard BioTools Inc.

SC 13G/A · Mar 20, 2024

15.3%

58.7M shares

APi Group Corporation

SC 13G/A · Mar 1, 2024

12.3%

32.0M shares

RayzeBio, Inc.

SC 13G/A · Feb 28, 2024

0.0%

0 shares

Pharvaris N.V.

SC 13G/A · Feb 14, 2024

7.0%

3.7M shares

Edgewise Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

9.7%

6.2M shares

APi Group Corporation

SC 13G/A · Feb 14, 2024

17.4%

42.5M shares

Amylyx Pharmaceuticals, Inc.

SC 13G/A · Feb 14, 2024

4.4%

3.0M shares

Adaptive Biotechnologies Corporation

SC 13G/A · Feb 14, 2024

20.7%

30.0M shares

Trevi Therapeutics, Inc.

SC 13G/A · Feb 14, 2024

10.0%

6.6M shares

Roivant Sciences Ltd.

SC 13G/A · Feb 14, 2024

8.6%

69.4M shares

* Rallybio Corporation

SC 13G/A · Feb 14, 2024

11.1%

4.2M shares

PepGen Inc.

SC 13G/A · Feb 14, 2024

6.2%

1.5M shares

Ginkgo Bioworks Holdings, Inc.

SC 13G/A · Feb 14, 2024

8.8%

143.1M shares

Valvoline Inc.

SC 13G/A · Feb 14, 2024

2.4%

3.2M shares

VIKING THERAPEUTICS, INC.

SC 13G/A · Feb 14, 2024

5.1%

5.1M shares

NewAmsterdam Pharma Company N.V.

SC 13G/A · Feb 14, 2024

9.7%

8.0M shares

Five9, Inc.

SC 13G/A · Feb 14, 2024

3.7%

2.7M shares

Verastem, Inc.

SC 13G/A · Feb 14, 2024

10.0%

2.5M shares

Inhibrx, Inc.

SC 13G/A · Feb 14, 2024

15.1%

7.2M shares

* ORIC Pharmaceuticals, Inc.

SC 13G · Jan 30, 2024

5.9%

4.0M shares

Standard BioTools Inc.

SC 13G · Jan 9, 2024

9.5%

29.1M shares

4D Molecular Therapeutics, Inc.

SC 13G/A · Jan 8, 2024

9.9%

4.2M shares

4D Molecular Therapeutics, Inc.

SC 13G/A · Jan 8, 2024

11.2%

4.8M shares

BridgeBio Pharma, Inc.

SC 13D/A · Nov 22, 2023

15.7%

25.1M shares

* VIKING THERAPEUTICS, INC.

SC 13G · Nov 2, 2023

5.9%

5.9M shares

* Five9, Inc.

SC 13G · Oct 6, 2023

5.1%

3.6M shares

* RayzeBio, Inc.

SC 13G · Sep 21, 2023

10.9%

6.6M shares

* Valvoline Inc.

SC 13G · Aug 24, 2023

6.0%

8.3M shares

BridgeBio Pharma, Inc.

SC 13D/A · Jul 20, 2023

15.7%

25.1M shares

Roivant Sciences Ltd.

SC 13G/A · Jun 26, 2023

9.9%

75.2M shares

* NewAmsterdam Pharma Company N.V.

SC 13G · Jun 20, 2023

8.0%

6.5M shares

* Verastem, Inc.

SC 13G · Jun 5, 2023

7.9%

1.3M shares

Pharvaris N.V.

SC 13G/A · Feb 14, 2023

9.7%

3.2M shares

Guardant Health, Inc.

SC 13G/A · Feb 14, 2023

4.0%

4.1M shares

Amylyx Pharmaceuticals, Inc.

SC 13G/A · Feb 14, 2023

7.0%

4.6M shares